Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (381-390 of 583) with videos related to

Pageof 59
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B StudyPeter Paschka, Guido Marcucci, Amy S Ruppert, et al.
Cancer|March 26, 2004
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251David A Rizzieri, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
MicroRNA fingerprints during human megakaryocytopoiesisRamiro Garzon, Flavia Pichiorri, Tiziana Palumbo, et al.
Blood|August 1, 2002
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720Maria R Baer, Stephen L George, Richard K Dodge, et al.
Leukemia|December 17, 2015
Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)B Bhatnagar, J S Blachly, J Kohlschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group BBruce A Peterson, Gina R Petroni, Glauco Frizzera, et al.
The New England Journal of Medicine|September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemiaR G Strauss, J E Connett, R P Gale, et al.
Haematologica|October 1, 2013
Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)Meir Wetzler, Dorothy Watson, Wendy Stock, et al.
Blood|October 24, 2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocolMartin S Tallman, Janet W Andersen, Charles A Schiffer, et al.
International Journal of Oncology|October 9, 2002
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461Sherif S Farag, Kellie J Archer, Krzysztof Mrózek, et al.
Pageof 59

Showing results (381-390 of 583) with videos related to

Sort By:
Pageof 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B StudyPeter Paschka, Guido Marcucci, Amy S Ruppert, et al.
Cancer|March 26, 2004
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251David A Rizzieri, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
MicroRNA fingerprints during human megakaryocytopoiesisRamiro Garzon, Flavia Pichiorri, Tiziana Palumbo, et al.
Blood|August 1, 2002
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720Maria R Baer, Stephen L George, Richard K Dodge, et al.
Leukemia|December 17, 2015
Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)B Bhatnagar, J S Blachly, J Kohlschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group BBruce A Peterson, Gina R Petroni, Glauco Frizzera, et al.
The New England Journal of Medicine|September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemiaR G Strauss, J E Connett, R P Gale, et al.
Haematologica|October 1, 2013
Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)Meir Wetzler, Dorothy Watson, Wendy Stock, et al.
Blood|October 24, 2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocolMartin S Tallman, Janet W Andersen, Charles A Schiffer, et al.
International Journal of Oncology|October 9, 2002
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461Sherif S Farag, Kellie J Archer, Krzysztof Mrózek, et al.
Pageof 59